CLINICAL_TRIALS
trial_result
· 2023-10-18
Clinical Trial Update: A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis [Phase 2]
Summary
Phase 2 trial updating the study of bran-brutinib (BMS-986166) for atopic dermatitis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Dermatitis, Atopic | Phase 2 | Status: COMPLETED | Results posted: 2023-10-18